Bilastine intermediate preparation method

A technology of bilastine and intermediates, applied in the field of medicinal chemistry, can solve the problems of high requirements for reaction equipment, difficulty in industrialization, and low reaction yield, and achieve the effects of high purity, no side reactions, and simple operation

Inactive Publication Date: 2016-01-27
万全万特制药江苏有限公司
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The literature mentions that in the preparation of intermediate 2-[1-(2-{4-[1-(4,4-dimethyl-4,5-2H-oxazol-2yl)-1-methyl-ethyl ]-phenyl}-ethyl)-piperidin-4-yl]-1H-benzimidazole adopts p-toluenesulfonyl chloride as an acylating reagent, because when utilizing p-toluenesulfonyl chloride to prepare, the reaction yield is low, only 65%, and the post-reaction treatment is difficult, and it is difficult to realize industrialization
In the subsequent nucleophilic substitution reaction of H on the benzimidazole ring, the sodium hydride used is a flammable and explosive reagent, which is relatively dangerous and requires high reaction equipment, which is a major hidden danger in industrial production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bilastine intermediate preparation method
  • Bilastine intermediate preparation method
  • Bilastine intermediate preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Dissolve 9.70 g of the compound 2-{1-[4-(2-hydroxyethyl)phenyl]-1-methylethyl}-4,5-2H-4,4-dimethyloxazole in dichloro In 50mL of methane, turn on the magnetic stirring, then dissolve 14.2g of trifluoromethanesulfonyl chloride in 10ml of dichloromethane, put it in a constant pressure dropping funnel, drop it into the reaction bottle, then add 8mL of triethylamine, and react at room temperature for 4h , TLC point plate monitoring shows that the raw material has reacted completely, and the saturated NaHCO 3 solution, water and NaCl solution extraction, the organic phase is concentrated into a yellow oily liquid, add an appropriate amount of ethyl acetate to dissolve it under heating, then add petroleum ether for beating until a large amount of solids are precipitated, freeze and filter (increase the yield ), dried to obtain 11.4 g of white powdery solid, (single point) yield was 86.1%.

[0016] Take 2-[4-(1-(4,4-Dimethyl-2H-oxazol-2-yl)-1-methylethyl)phenyl]ethyl triflate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a Bilasiting intermediate 2-[1-(2-{4-[1-(4,4-dimethyl-4,5-2H-oxazol-2-yl)-1-methyl-ethyl]-phenyl}-ethyl)-piperidin-4-yl]-1H-benzimidazole preparation method, the compound 2-{1-[4-(2-hydroxyethyl) phenyl]-1-methylethyl}-4,5-2H-4,4-dimethyl-oxazole is dissolved in an organic solvent, trifluoromethanesulfonyl chloride is dissolved, and added dropwise to the system, after the completion of the addition, triethylamine is added for heating and refluxing for 1h to obtain structure II compound 2-[4-(1-(4,4-dimethyl-2H-oxazol-2-yl)-1-methylethyl) phenyl] ethyl triflate, and the resulting compound 2-[4-(1-(4,4-dimethyl-2H-oxazol-2-yl)-1-methylethyl) phenyl] ethyl triflate is dissolved in an organic solvent, under nitrogen protection, sodium methoxide is added for reaction for 2 h, 2-(4-piperidine)-1 H-benzimidazole is added for heating and refluxing for 2h to obtain 2-[1-(2-{4-[1-(4,4-dimethyl-4,5-2H-oxazol-2-yl)-1-methyl-ethyl]-phenyl}-ethyl)-piperidin-4-yl]-1H-benzimidazole.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry and relates to bilastine intermediate 2-[1-(2-{4-[1-(4,4-dimethyl-4,5-2H-oxazol-2 base)- Preparation of 1-methyl-ethyl]-phenyl}-ethyl)-piperidin-4-yl]-1-(2-ethoxy-ethyl)-1H-benzimidazole. Background technique [0002] Bilastine is the second generation of histamine H developed by Spanish FAES pharmaceutical company 1 Receptor antagonist, approved by the European Union in 2010 for the treatment of allergic rhinitis and chronic idiopathic urticaria. This product is safe, without the sedative effect and cardiotoxicity of commonly used antihistamines. [0003] [0004] The literature mentions that in the preparation of intermediate 2-[1-(2-{4-[1-(4,4-dimethyl-4,5-2H-oxazol-2yl)-1-methyl-ethyl ]-phenyl}-ethyl)-piperidin-4-yl]-1H-benzimidazole adopts p-toluenesulfonyl chloride as an acylating reagent, because when utilizing p-toluenesulfonyl chloride to prepare, the reaction yield is low, only ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D413/14
CPCC07D413/14
Inventor 李恩民王进敏
Owner 万全万特制药江苏有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products